CMX-2043
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CMX-2043, covering 2011-06-20 to 2016-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography [Phase 2]